Revolutionizing Healthcare: Emerging Frontiers in 3D Bioprinting of Tissues and Organs
Ochieng Ben Omondi,Yasinta Nida Arroyan,Benson Onyango,Lingwen Kong,Guixue Wang,Zhiyi Ye
DOI: https://doi.org/10.1016/j.eurpolymj.2024.113210
2024-01-01
Abstract:Tissue engineering and regenerative medicine field, which focuses on creating functional tissue constructs resembling native tissue to repair or replace damaged tissues or organs, has undergone rapid evolution in recent decades. Particularly, there has been a surge of interest in utilizing tissue engineering for treating cardiovascular diseases, utilizing both natural and synthetic blood vessels. Additionally, advancements in bio-printing hold promise for generating human-engineered tissues like bone and skin for clinical applications. However, traditional tissue engineering methods, involving the scaffolds used, growth factors, and cells, have faced challenges in fabricating complex 3D shapes and achieving in vivo organ regeneration, making them less feasible for clinical use due to logistical and economic constraints. Various techniques, such as Electrospinning, Molding, Cell Sheet Rolling, and Decellularization, have been explored, but they have limitations, prompting the investigation of 3D bioprinting techniques. The advantages of 3D bioprinting over other biofabrication techniques are manifold. Firstly, the technique enables the advanced and precise layer-by-layer assembly of cells and biomaterials. Secondly, the utilization of a 3D bioprinter to create replicas based on medical images allows for the fabrication of complex tissues. Thirdly, the construction of tissue models through layering provides control over the precise placement of biomaterials and cells. Additionally, the use of 3D bioprinting allows for significant advancements in bioink modification, resulting in more accurate tissue replicas for practical in vivo tissue regeneration. Furthermore, 3D bioprinting enables the printing of tissues from undifferentiated stem cells obtained from the patient, reducing the risk of tissue rejection in native vessels. This paper reviews the applications of 3D bioprinting in engineered human tissues such as skin, bones and artificial blood vessels for cardiovascular diseases treatments. It provides an overview of 3D bioprinting technology and strategies, including ink-jet printing, extrusion printing, and stereolithography. The review then focuses on the applications of 3D bioprinting in constructing various tissues and organs, including cardiac, skin, and bone, discussing the steps involved and the technological requirements based on recent review and research articles. Finally, the review underscores the merits of the 3D bioprinting technique and outlines its current state while providing insights into future innovations aimed at skin tissue, bone tissue and blood vessels bioprinting. It explores potential advancements in polymer and biomaterial usage, cell sources, oxygen provision to cells, hydrogel and scaffold utilization, integration of machine learning, combining 3D bioprinting with 4D bioprinting, and addressing the expenses associated with 3D bioprinting, along with recommended cost mitigation methodologies.